Previous studies have shown that in estrogen receptor (ER) positive early breast cancer patients, endocrine therapeutic procedures reduce recurrences and the mortality rate, regardless of whether chemotherapy is also applied [70]. The gene discussed is ESR1; the disease is breast carcinoma.